Artículo
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Fecha de publicación:
04/03/2019
Editorial:
John Wiley & Sons Inc
Revista:
Clinical Liver Disease
ISSN:
2046-2484
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Hepatitis C virus (HCV) infection is a global health concern with an estimated worldwide disease prevalence rate of 1%, meaning 71 million individuals are infected.1 In the United States, the estimated prevalence rate is 0.7%, or 7 million individuals.1 Specifically in Latin America, estimations suggest that only 25% of individuals with suspected HCV infection have been diagnosed, and only 4% received treatment.2 Recent availability in this region of directacting antivirals (DAAs), which are safer and more effective than the interferon-based therapies, may influence treatment paradigms at country levels.
Palabras clave:
HEPATITIS C
,
ERRADICATION
,
LATIN AMERICA
,
TREATMENT
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(CEMIC-CONICET)
Articulos de CENTRO DE EDUCACION MEDICA E INVESTIGACIONES CLINICAS "NORBERTO QUIRNO"
Articulos de CENTRO DE EDUCACION MEDICA E INVESTIGACIONES CLINICAS "NORBERTO QUIRNO"
Citación
Ridruejo, Ezequiel; Soza, Alejandro M. D.; Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?; John Wiley & Sons Inc; Clinical Liver Disease; 13; 2; 4-3-2019; 43-45
Compartir
Altmétricas